Clinical Trials Logo

Filter by:
NCT ID: NCT00999219 Completed - Clinical trials for Sleep Initiation and Maintenance Disorders

A Study of FK199B to Compare Efficacy With Zolpidem by Polysomnography in Patients With Insomnia

Start date: March 2006
Phase: Phase 3
Study type: Interventional

This study is to investigate the efficacy and safety of FK199B (Zolpidem MR Tablet) by polysomnography in patients with insomnia, excluding patients with schizophrenia or manic-depressive psychosis.

NCT ID: NCT00998881 Completed - Clinical trials for Type 2 Diabetes Mellitus

Monotherapy Study of MP-513 in Patients With Type 2 Diabetes

Start date: September 2009
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of MP-513 (Teneligliptin) in patients with type 2 Diabetes for 12 weeks administration.

NCT ID: NCT00997802 Completed - Colonic Neoplasms Clinical Trials

Japanese National Computed Tomographic (CT) Colonography Trial

JANCT
Start date: October 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the sensitivity of computed tomographic colonography (CTC) in detecting colorectal polyps and cancers in 1,500 subjects at increased risk of colorectal cancer (CRC), using optical colonoscopy as the reference standard.

NCT ID: NCT00997594 Completed - Adrenal Tumors Clinical Trials

Changes in Adrenal Hormones During Adrenal Radiofrequency Ablation

Start date: October 2009
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to evaluate changes in adrenal hormones during adrenal radiofrequency (RF) ablation.

NCT ID: NCT00997282 Completed - Diabetes Type 2 Clinical Trials

A Study of OPC-262 in Patients With Type 2 Diabetes

Start date: September 2009
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this clinical study is to evaluate the superiority of the efficacy of OPC-262 (2.5 mg, and 5 mg) to placebo in patients with type 2 diabetes after 24 week treatment in a double-blind fashion and to evaluate the safety of OPC-262 to placebo.

NCT ID: NCT00996476 Completed - Clinical trials for Hepatitis C, Chronic

A Study to Assess the Effectiveness, Safety, and Pharmacokinetics of TMC435 in Combination With Peginterferon Alfa-2a and Ribavirin in Hepatitis-C Infected Patients

DRAGON
Start date: July 2009
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate effectiveness, safety and pharmacokinetics (Explores what the body does to the medication) of TMC435350 in combination with Peginterferon Alfa-2a and Ribavirin in genotype 1 hepatitis C virus infected Japanese participants who have never received treatment for their hepatitis C infection.

NCT ID: NCT00996138 Completed - Influenza Clinical Trials

Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Adult Subjects

Start date: September 2009
Phase: Phase 2/Phase 3
Study type: Interventional

This study is to identify the preferred vaccine dosage (of antigen and adjuvant) and schedule (one or two administrations) of the cell-derived H1N1sw monovalent vaccine in healthy adults based on EMEA/CHMP criteria, and safety & tolerability.

NCT ID: NCT00995163 Completed - Clinical trials for End Stage Renal Disease

Mineral and Bone Disorders Outcomes in Stage 5D of Chronic Kidney Disease

MBD-5D
Start date: January 2008
Phase: N/A
Study type: Observational

The MBD-5D is a prospective observational study with a case-cohort and a cohort design. Eligible patients are receiving hemodialysis and have secondary hyperparathyroidism. The study's three goals are (1) to record the patients' characteristics, and variation in the patterns of their treatment; (2) to analyze factors associated with variation in those medical practice patterns; and (3) to identify practice patterns and other factors that affect hospitalization, mortality, and other patient-level outcomes.

NCT ID: NCT00994461 Completed - Healthy Volunteers Clinical Trials

Study Of Celecoxib In Healthy Subjects

Start date: November 2009
Phase: Phase 4
Study type: Interventional

A study to confirm the superiority of celecoxib 100 mg BID to loxoprofen 60 mg TID in the incidence of gastroduodenal endoscopic ulcers after 2 weeks treatment.

NCT ID: NCT00993382 Completed - Clinical trials for Ventricular Arrhythmia

Dose Ranging Study of Celivarone With Amiodarone as Calibrator for the Prevention of Implantable Cardioverter Defibrillator (ICD) Interventions or Death

ALPHEE
Start date: September 2009
Phase: Phase 2
Study type: Interventional

The Primary Objective was to assess the efficacy of celivarone for the prevention of Implantable Cardioverter Defibrillator (ICD) interventions or death. Secondary Objectives were: - To assess the tolerability and safety of the different dose regimens of celivarone in the selected population. - To document SSR149744 plasma levels during the study.